Below are the most recent publications written about "Prognosis" by people in Profiles.
-
Tringale KR, Jenabi M, Kohli J, Jackson C, Hattangadi-Gluth JA, McDonald CR, Fahy T, Ramjan S, Sands S, Holodny A, Wolden SL, Vachha BA. Functional neuroimaging biomarkers of impaired neurocognition after proton beam radiotherapy for brain tumors in pediatric patients: A prospective trial. Neuro Oncol. 2026 Jul 01; 28(7):1794-1807.
-
Willis KD, Forst DA, Horick N, Strander SM, Whitman J, Corveleyn A, Sannes T, Temel JS, Greer JA, El-Jawahri A, Jacobs JM. Improved coping and self-efficacy drive improvements in mood among caregivers of patients with primary malignant brain tumors: Results from a randomized controlled trial. Neuro Oncol. 2026 Jul 01; 28(7):1741-1752.
-
Kramer CM, Kolm P, DiMarco JP, Desai MY, Ho CY, Kwong RY, Dolman SF, Desvigne-Nickens P, Geller N, Kim DY, Schulz-Menger J, Friedrich MG, Maron MS, Appelbaum E, Link MS, Francis GS, Greenberg B, Jerosch-Herold M, Piechnik S, Mahmod M, Raman B, Jacoby DL, Baldassare LA, White JA, Chiribiri A, Helms AS, Choudhury L, Michels M, Bradlow WM, Salerno M, Heitner SB, Masri A, Prasad SK, Mohiddin SA, Plein S, Madias C, Mahrholdt H, Bucciarelli-Ducci C, Nightingale AK, Weinsaft JW, Kim HW, McCann GP, van Rossum A, Germans T, Williamson EE, Geske JB, Flett AS, Dawson D, Mongeon FP, Olivotto I, Crean AM, Woo A, Owens AT, Anderson L, Sharma S, Biagini E, Newby DE, Andre F, Berry C, Kim B, Larose E, Abraham TP, Hays AG, Sherrid MV, Gelfand EV, Nagueh SF, Rimoldi O, Camici P, Elstein E, Autore C, Watkins H, Weintraub WS, Neubauer S. Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy: The NHLBI HCM Registry. JAMA. 2026 Jun 09; 335(22):1959-1969.
-
Maclachlan KH, Tan CR, Shekarkhand T, Rueda C, Derkach A, Hashmi H, Hassoun H, Shah UA, Hultcrantz M, Lesokhin AM, Mailankody S, Maura F, Merz M, Firestone R, Jurgens EM, Miller KC, Rajeeve S, Giralt S, Shah GL, Scordo M, Landau HJ, Zhang Y, Cimera R, Arcila ME, Korde N, Usmani SZ. IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM. Blood Adv. 2026 Apr 28; 10(8):2616-2625.
-
Hashmi H, Sebastian T, Rajeeve S, Farzana T, Firestone RS, Jurgens EM, Miller KC, Maura F, Lesokhin AM, Tan CR, Shah GL, Korde N, Landau HJ, Merz M, Scordo M, Hassoun H, Maclachlan KH, Shah UA, Hultcrantz ML, Derkach A, Nemirovsky D, Giralt S, Mailankody S, Usmani SZ. Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma. Blood Cancer J. 2026 Apr 12; 16(1).
-
Mohty R, Narra R, Mims AS, Hunter C, Shallis RM, Kota V, Jamy O, Coltoff A, Othman TA, Jonas BA, Patel AA, DuVall AS, Foucar CE, Abdelsamia M, Palmisiano N, Patel SA, Curran E, Omer Z, Advani A, Atallah E, Litzow MR, Badar T. Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Leuk Lymphoma. 2026 Jun; 67(7):1587-1594.
-
Mainali S, Fontaine GV, Rajajee V, Montellano FA, Muehlschlegel S, Wartenberg KE, Alexander SA, Busl KM, Hocker SE, Hwang DY, Kim KS, Madzar D, Mahanes D, Meixensberger J, Sakowitz OW, Varelas PN, Weimar C, Westermaier T, Creutzfeldt CJ. Guidelines for Neuroprognostication in Critically ill Adults with Acute Ischemic Stroke. Neurocrit Care. 2026 Jun; 44(3):745-769.
-
Maron BJ, Ommen SR, Nishimura RA, McKenna WJ, Rakowski H, Sherrid MV, Olivotto I, Braunwald E, Maron MS. Evolution and Transformation of Hypertrophic Cardiomyopathy From a High Risk to a Treatable Low Mortality Disease With Contemporary Clinical Research Strategies. J Am Heart Assoc. 2026 Jun 16; 15(12):e047462.
-
Qu W, Jia J, Zhang N, Wang R, Liu Y, Zhang S, Gao H, Tao Y, Jia L, Liu Y, Zhao J. Oncogenic role of PHF23 in gastric cancer progression. Funct Integr Genomics. 2026 Mar 04; 26(1).
-
Paladino J, Schofield C, Angove R, Murphy A, Sanders JJ, Hasan M, Davila C, Downey N, Auger B, Downey S, Mitchell SE, Fromme EK. Redesigning a Serious Illness Conversation Guide: A Mixed-Methods Community-Engaged Revision Process. J Pain Symptom Manage. 2026 Mar; 71(3):e245-e260.